Ultragenyx Pharmaceutical Inc. — Form D

Ultragenyx Pharmaceutical Inc. of Novato, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-03-16. The offering totals $133, of which $133 was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
Bill AliskiDirectorNovato, CA
EMIL KAKKISDirectorNOVATO, CA
John KlockDirectorNovato, CA
Jenny SorianoDirectorNovato, CA
John DittonExecutive OfficerNovato, CA
EMIL KAKKISExecutive OfficerNOVATO, CA
Ben AuspitzDirectorCambridge, MA
Marten SteenDirectorLausanne, V8
William AliskiDirectorNovato, CA
Eran NadavDirectorSan Francisco, CA
MARTEN D STEENDirectorNOVATO, CA
SHALINI D SHARPExecutive OfficerNOVATO, CA
VIMAL D SRIVASTAVAExecutive OfficerNOVATO, CA
THOMAS D KASSBERGExecutive OfficerNOVATO, CA
BEN D AUSPITZDirectorNOVATO, CA
EMIL D KAKKISDirectorNOVATO, CA
EMIL D KAKKISExecutive OfficerNOVATO, CA
STEVEN D JUNGLESExecutive OfficerNOVATO, CA
CORDELIA D LEONARDExecutive OfficerNOVATO, CA
JOHN D DITTONExecutive OfficerNOVATO, CA
ERAN D NADAVDirectorNOVATO, CA
WILLIAM D ALISKIDirectorNOVATO, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2012-12-31D$75.0M$75.0M
2012-07-30D$30.1M$15.1M
2011-06-23D$48.7M$18.7M

More